# Revolution Medicines reiterates $2.1B-$2.2B 2026 GAAP operating expense guidance following RASONQUE launch

- Source: Seeking Alpha Market Currents
- Published: 2026-11-05T01:35:21+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4666025-revolution-medicines-reiterates-2_1b-2_2b-2026-gaap-operating-expense-guidance-following?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/revolution-medicines-reiterates-2-1b-2-2b-2026-gaap-operating-expense--b7981d/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._